Patients with non-Hodgkin lymphoma including chronic lymphocytic leukemia (NHL/CLL) are at higher risk of severe SARS-CoV-2 infection. We investigated vaccine-induced antibody responses in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback